Urovant Sciences to Present New Ambulatory Blood Pressure Da

Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA (vibegron) 75 mg for Overactive Bladder at the Virtual 2021 Annual Meeting of the American Urological Association

Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA (vibegron) 75 mg for Overactive Bladder at the Virtual 2021 Annual Meeting of the American Urological Association

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , New York , United States , Boston , Massachusetts , Japan , Brooklyn , London , City Of , United Kingdom , Americans , American , Sumitomo Dainippon Pharma , Maya Frutiger , Benjaminm Brucker , David Staskin , Mary Frances Faraji , Sumitovant Biopharma , Alanj Wein , Roger Dmochowski , Michaela Weber , Cornelia Haag Molkenteller , Drug Administration , American Urological Association , Pelvic Health , Urovant Sciences Inc , Dainippon Pharmaceutical Co Ltd , Corporate Communications , European Union , Tufts University School Of Medicine , Sumitomo Dainippon Pharma Co Ltd , Urovant Sciences , Meeting Of The American Urological Association , Sumitovant Biopharma Ltd , Sumitomo Pharmaceuticals Co Ltd , Elizabeth Medical Center , Chief Medical Officer , Downstate College , State University , Ambulatory Blood Pressure , Overactive Bladder , Double Blind Study , Tufts University School , Female Pelvic Health , Medical Center , Dry Overactive Bladder , Subgroup Analysis , Treatment Strategies , Improve Patient Outcomes , Product Information , New York City , Sumitomo Dainippon , Dainippon Pharma , Frances Faraji ,